Filing Details

Accession Number:
0001725160-21-000235
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-07 20:35:25
Reporting Period:
2021-12-06
Accepted Time:
2021-12-07 20:35:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1725160 Zentalis Pharmaceuticals Inc. ZNTL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557832 Cam Gallagher C/O Zentalis Pharmaceuticals, Inc.
530 Seventh Avenue, Suite 2201
New York NY 10018
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-12-06 10,000 $71.33 427,203 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021.